Trustee: No Indication Madoff Bought Securities

The trustee in charge of untangling the mess brought on by the Bernard Madoff scandal told investors Friday there was no indication the financier bought securities for his clients.

Sections:  news   business   
RELATED ARTICLES
  • Lautenberg charity, others lose bid to revive Madoff claims
    A federal appeals court rejected a bid by former Bernard Madoff investors, including a charitable foundation for New Jersey Senator Frank Lautenberg, to pursue claims against family members of the imprisoned swindler. More
  • DealBook: Ex-Peregrine Chief Sentenced to 50 Years in Prison
    A prominent futures-industry executive, Russell Wasendorf Sr., was sentenced to 50 years in prison on Thursday for embezzling from his clients and defrauding banks over nearly two decades. More
  • Son of Peregrine CEO Says Fraud Devastating
    The son of the disgraced chief of Peregrine Financial said he has been personally and financially devastated by his father's fraud, which brought down the firm and left investors facing tens of millions of dollars in losses. More
  • Ex-Stanford executive gets 5 years in $7B swindle
    The star prosecution witness in the trial of convicted Texas financier R. Allen Stanford was sentenced Tuesday to five years in prison for helping to bilk investors out of more than $7 billion in one of the biggest Ponzi schemes in U.S. More
  • Bernard Madoff's Brother Gets 10-Year Sentence
    The brother of imprisoned financier Bernard Madoff was sentenced Thursday to 10 years in prison for crimes committed in the shadow of his notorious sibling by a judge who said she disbelieved his claims that he did not know about the epic fraud. More
BING NEWS:
  • Don't Get Duped By These 'Sucker Yields'
    Learn from Bernie Madoff's cautionary tale and be skeptical of high returns. Click to see several REITs that in our view have unsustainable yields.
    05/1/2024 - 12:00 am | View Link
  • X4 Pharmaceuticals: FDA Approval For WHIM Warrants Further Upside
    X4 Pharmaceuticals, Inc. received FDA approval for mavorixafor in WHIM syndrome, along with a priority review voucher. Click here ton read my XFOR update.
    04/29/2024 - 10:02 am | View Link
  • More

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News